Share Search
Visit the Share Search
Poolbeg Pharma Accounts Summary
| Date of Accounts | 2023 | 2022 | 2021 | ||
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | ||
| Millions | Millions | Millions | |||
| Income Statement | 31-12-2023 | 31-12-2022 | 31-12-2021 | ||
| Revenue | n/a | n/a | n/a | ||
| Operating Profit / Loss | -5.04 | -4.99 | -2.34 | ||
| Net Interest | 0.53 | 0.21 | n/a | ||
| Pre Tax Profit | -4.50 | -4.78 | -2.34 | ||
| Post Tax Profit | -3.93 | -4.69 | -2.34 | ||
| Profit for the Period | -3.93 | -4.69 | -2.34 | ||
| Equity Holders of Parent Company | -3.93 | -4.69 | -2.34 | ||
| Minority Interests | n/a | n/a | n/a | ||
| Continuing EPS | |||||
| Earnings per Share (Basic) | -0.79p | -0.94p | -0.74p | ||
| Earnings per Share (Diluted) | -0.79p | -0.94p | -0.74p | ||
| Earnings per Share (Adjusted) | -0.79p | -0.94p | -0.74p | ||
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -0.79p | -0.94p | -0.74p | ||
| Earnings per Share (Diluted) | -0.79p | -0.94p | -0.74p | ||
| Earnings per Share (Adjusted) | -0.79p | -0.94p | -0.74p | ||
| Dividend per Share | n/ap | n/ap | n/ap | ||
| Millions | Millions | Millions | |||
| Balance Sheet | 31-12-2023 | 31-12-2022 | 31-12-2021 | ||
| Non-Current Assets | |||||
| Intangible Assets | 1.93 | 2.13 | 1.56 | ||
| Property, Plant and Equipment | n/a | n/a | n/a | ||
| Investments | n/a | n/a | n/a | ||
| Investment Properties | n/a | n/a | n/a | ||
| Other Financial Assets | n/a | n/a | n/a | ||
| Other Non-Current Assets | n/a | n/a | n/a | ||
| Total Non-Current Assets | 1.93 | 2.13 | 1.56 | ||
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | ||
| Trade and Other Receivables | 1.33 | 0.96 | 0.51 | ||
| Cash at Bank and in Hand | 12.17 | 16.19 | 20.95 | ||
| Current Asset Investments | n/a | n/a | n/a | ||
| Other Current Assets | n/a | n/a | n/a | ||
| Total Current Assets | 13.50 | 17.16 | 21.45 | ||
| Other Assets | n/a | n/a | n/a | ||
| Total Assets | 15.43 | 19.29 | 23.02 | ||
| Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | ||
| Other Current Liabilities | 0.99 | 0.97 | 0.44 | ||
| Total Current Liabilities | 0.99 | 0.97 | 0.44 | ||
| Net Current Assets | n/a | n/a | n/a | ||
| Non-Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | ||
| Provisions | n/a | n/a | n/a | ||
| Other Non-Current Liabilities | n/a | n/a | n/a | ||
| Total Non-Current Liabilities | n/a | n/a | n/a | ||
| Net Assets | 14.44 | 18.32 | 22.58 | ||
| Capital and Reserves | |||||
| Share Capital | 0.10 | 0.10 | 0.10 | ||
| Share Premium Account | 23.10 | 23.10 | 23.10 | ||
| Other Reserves | 2.19 | 2.15 | 1.72 | ||
| Retained Earnings | -10.95 | -7.02 | -2.34 | ||
| Shareholders Funds | 14.44 | 18.32 | 22.58 | ||
| Minority Interests / Other Equity | n/a | n/a | n/a | ||
| Total Equity | 14.44 | 18.32 | 22.58 | ||
| 31-12-2023 | 31-12-2022 | 31-12-2021 | |||
| Operating Margin | n/a% | n/a% | n/a% | ||
| Return on Capital Employed | -40.27% | -30.80% | -11.11% | ||
| Dividend Cover | n/a | n/a | n/a | ||
| Dividend Yield | n/a | n/a | n/a | ||
| PE Ratio | n/a | n/a | n/a | ||
| PEG | n/a | n/a | n/a | ||
| Dividend per Share Growth | n/a% | n/a% | n/a% | ||
| Net Asset Value per Share | 2.50p | 3.24p | 4.20p |